Axolotl Biosciences just secured $265K in co-funding and aims to impact brain, heart, and stem cell research. By Martin Bauman What if you could print healthy brain tissue, or brain… Read More
Vabysmo (faricimab) simultaneously targets and inhibits two disease pathways that drive neovascular or “wet” age-related macular degeneration (nAMD) and diabetic macular edema (DME) The CHMP recommendation is based on results across four phase… Read More
Burnaby, BC – Qu Biologics Inc., a private clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore innate immune function, is pleased to… Read More
Researchers discover breadth of cancer information by examining DNA with a simple blood test. Researchers at the Vancouver Prostate Centre and BC Cancer have developed a new blood test that… Read More
– Alliance will provide opportunity for AbbVie to further expand its diverse eye care portfolio and provide additional treatment options for glaucoma patients – Collaboration further supports the role of MINIject® in… Read More
